Severity of chronic obstructive pulmonary disease and risk of one-year mortality after first-time implantation of implantable cardioverter defibrillator: a nationwide study

29 August 2022 (13:15 - 13:45)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Amna Alhakak

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail

Driving restrictions following defibrillator implantation significantly affect recipients' ability to maintain employment

Doctor J. Bjerre (Hilleroed, DK)

Abstract Slides

Presentation thumbnail

History of betablocker treatment breaks and risk of ventricular tachyarrhythmias among patients with heart failure and implantable cardioverter defibrillator: a nationwide cohort study

Miss E. Mc Evoy Kjaer (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Effect of defibrillator on long term all-cause mortality in patients with chronic kidney disease: an updated meta-analysis

Doctor F. Aslam (Stony Brook, US)

Abstract Slides

Presentation thumbnail

The role of trigger factors in the occurrence of appropriate ICD shocks and their prognostic implications

Doctor T. Kleemann (Ludwigshafen, DE)

Abstract Slides

Presentation thumbnail

The case against premature treatment of heart failure patients with implantable cardioverter-defibrillators: results from an institutional registry

Doctor I. Prepolec (Zagreb, HR)

Abstract Slides

Access the full session

Session thumbnail

Real-world data in ICD treatment

The Event

Event poster

ESC Congress 2022

29 August 2022 13:15 CET

You may be interested in

Congress Session

Debate on primary prevention in ICD therapy

Congress Session

Implantable cardioverter defibrillator therapy

Congress Session

Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources